ursodeoxycholic acid has been researched along with Amyotrophic Lateral Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa, M; Brites, D; Cunha, C; Gomes, C; Schmucki, N; Vaz, AR | 1 |
| Hong, YH; Kim, SM; Lee, JB; Lee, KW; Min, JH; Sung, JJ | 1 |
1 review(s) available for ursodeoxycholic acid and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
ALSUntangled no. 25: ursodiol.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cholagogues and Choleretics; Humans; Ursodeoxycholic Acid | 2014 |
1 trial(s) available for ursodeoxycholic acid and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial.
Topics: Administration, Oral; Amyotrophic Lateral Sclerosis; Cholagogues and Choleretics; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebo Effect; Severity of Illness Index; Ursodeoxycholic Acid; Vital Capacity | 2012 |
1 other study(ies) available for ursodeoxycholic acid and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Glycoursodeoxycholic acid reduces matrix metalloproteinase-9 and caspase-9 activation in a cellular model of superoxide dismutase-1 neurodegeneration.
Topics: Amyotrophic Lateral Sclerosis; Animals; Caspase 9; Disease Models, Animal; Matrix Metalloproteinase 9; Mice; Motor Neurons; Mutation; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Ursodeoxycholic Acid | 2015 |